Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Medipharm Labs Corp
T.LABS
Alternate Symbol(s):
MEDIF
Healthcare
Cannabis
MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes,...
packages and distributes cannabis extracts and advanced cannabinoid-based products to domestic and international markets. It also provides GMP flower sourcing, packaging, and distribution services for select international clients. In addition, it cultivates cannabis to sell as dried flower, pre-roll and other cannabis products for the adult use and medical markets. It also sells metered dose inhalers and aerosol sublingual sprays. Through Harvest Medicine, it provides clinic services to Canadian patients requiring medical cannabis education and prescriptions.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (TSX:LABS)
New Post
View:
Posts & Comments
Threaded Posts
Prev
...
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
118
119
120
...
Next
(571)
•••
mdjbrown
X
View Profile
View Bullboard History
Comment by
mdjbrown
on Mar 07, 2024 2:41pm
RE:FDA approval
Congrats Starkicker. Always fantastic to see retail investors rewarded for their patience. Medipharm's time will come, albeit not fast enough for many folks here........ but it will
...more
(615)
•••
okgonow
X
View Profile
View Bullboard History
Comment by
okgonow
on Mar 07, 2024 2:30pm
RE:So when LABS CEO stated they have over 20 'strong' clinical
a year ago...............tgere are cobwebs on that NR
(80)
•••
Starkicker
X
View Profile
View Bullboard History
Post by
Starkicker
on Mar 07, 2024 2:15pm
FDA approval
One of my other holdings, MMED, just received breakthrough FDA approval for psilocybin medicine for anxiety disorder. It's up 53% today. The company had been silent for more than a year. Hopefully
...more
(603)
•••
subaru1i
X
View Profile
View Bullboard History
Post by
subaru1i
on Mar 07, 2024 2:04pm
So when LABS CEO stated they have over 20 'strong' clinical
trials, many in late stage then you have to ask yourself where are they all being conducted? We already know the "who"...with their 'large traditional global phamaceutical partner&
...more
(615)
•••
okgonow
X
View Profile
View Bullboard History
Post by
okgonow
on Mar 07, 2024 12:10pm
NR's
are as rare as henns teeth from this company. I dont need a day to day or weekly Nr from a company stating irrellevant things jbut these guys have absolutly nothing for shareholders. it wouldent be
...more
(137)
•••
subaru1
X
View Profile
View Bullboard History
Comment by
subaru1
on Mar 07, 2024 11:59am
RE:An update from Labs on the LiBBY study would be nice
Life's End Benefits of Cannabidiol and Tetrahydrocannabinol (LiBBY) ClinicalTrials.gov ID NCT05644262 Sponsor University of Southern California Information provided by&
...more
(603)
•••
subaru1i
X
View Profile
View Bullboard History
Post by
subaru1i
on Mar 07, 2024 11:51am
mdjbrown, NOT a coincidence Pfizer collaboration at USC
including cancer. Please enjoy the snippet below followed below with link. PS....'Not a coincidence' IS confirmed ;-) Anthony Coyle, vice president and chief scientifi
...more
(264)
•••
alleyesonme
X
View Profile
View Bullboard History
Comment by
alleyesonme
on Mar 07, 2024 11:50am
RE:RE:RE:RE:RE:Great time for Labs to use German news to their advantage
Absolutely ridiculous to be invested in a Corp you believe to be lying to shareholders..are you not concerned about the fallout from making false statements on the investor deck....here we go with the
...more
(571)
•••
mdjbrown
X
View Profile
View Bullboard History
Post by
mdjbrown
on Mar 07, 2024 11:29am
An update from Labs on the LiBBY study would be nice
https://www.newswire.ca/news-releases/medipharm-labs-enters-cannabis-research-agreement-with-keck-school-of-medicine-of-usc-865838274.html https://classic.clinicaltrials.gov/ct2/show/NCT05644262
(137)
•••
subaru1
X
View Profile
View Bullboard History
Comment by
subaru1
on Mar 07, 2024 11:17am
RE:RE:RE:RE:Great time for Labs to use German news to their advantage
You are right Okgonow, he is almost there, anyway since he is on this chat withs is different nickname he has never been right on any of his predictions. He must be using the old crystal bal of
...more
(615)
•••
okgonow
X
View Profile
View Bullboard History
Comment by
okgonow
on Mar 07, 2024 7:21am
RE:RE:RE:Great time for Labs to use German news to their advantage
pretty soon he will just be posting to himself .....it will be a very valuable discussion between he, himself, and his imaginary friend !!
(131)
•••
QContinuum1
X
View Profile
View Bullboard History
Comment by
QContinuum1
on Mar 07, 2024 7:00am
RE:RE:Great time for Labs to use German news to their advantage
Does old make it wrong? Go to the clinical trials website yourself and you'll find that each of those are as stated. Not late stage by any measure.
(603)
•••
subaru1i
X
View Profile
View Bullboard History
Comment by
subaru1i
on Mar 06, 2024 8:58pm
RE:RE:Great time for Labs to use German news to their advantage
Another one out of the wood work creating doubt where there is no doubt. News must be getting close eh Kwestion. You win the ignore button award as well.
(0)
•••
Kwestion
X
View Profile
View Bullboard History
Comment by
Kwestion
on Mar 06, 2024 8:12pm
RE:Great time for Labs to use German news to their advantage
That's an old article
Prev
...
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
118
119
120
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >